Natural killer cell immunotherapy for cancer: a new hope.

Srivastava, S; Lundqvist, A; Childs, R W

Srivastava, S; Lundqvist, A; Childs, R W.

Affiliation

Srivastava S; National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.

Cytotherapy ; 10(8): 775-83, 2008.

Article in En | MEDLINE | ID: mdl-19089686

Subject(s)

Immunotherapy, Adoptive/trends; Killer Cells, Natural/immunology; Neoplasms/immunology; Neoplasms/therapy; Receptors, KIR/metabolism; Recombinant Fusion Proteins/metabolism; Animals; Antibody-Dependent Cell Cytotoxicity/immunology; Apoptosis Regulatory Proteins/immunology; Apoptosis Regulatory Proteins/metabolism; Combined Modality Therapy; Cytotoxicity, Immunologic/genetics; Cytotoxicity, Immunologic/immunology; Feedback, Physiological/genetics; Feedback, Physiological/immunology; Graft vs Tumor Effect/immunology; Histocompatibility; Humans; Immunotherapy, Adoptive/methods; Killer Cells, Natural/metabolism; Neoplasms/pathology; Receptors, KIR/genetics; Receptors, KIR/immunology; Recombinant Fusion Proteins/genetics; Recombinant Fusion Proteins/immunology; Transfection

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Killer Cells, Natural / Immunotherapy, Adoptive / Receptors, KIR / Neoplasms Limits: Animals / Humans Language: En Journal: Cytotherapy Journal subject: TERAPEUTICA Year: 2008 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google